0001022079-16-000263.txt : 20160516
0001022079-16-000263.hdr.sgml : 20160516
20160516162525
ACCESSION NUMBER: 0001022079-16-000263
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160512
FILED AS OF DATE: 20160516
DATE AS OF CHANGE: 20160516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRITELL JENNE K
CENTRAL INDEX KEY: 0001142318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 161654244
MAIL ADDRESS:
STREET 1: 100 FIRST STAMFORD PLACE
STREET 2: SUITE 700
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
wf-form4_146343031282306.xml
FORM 4
X0306
4
2016-05-12
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001142318
BRITELL JENNE K
C/O QUEST DIAGNOSTICS
3 GIRALDA FARMS
MADISON
NJ
07940
1
0
0
0
Common Stock
2016-05-12
4
M
0
8000
51.55
A
19655
I
by Trust
Common Stock
2016-05-12
4
S
0
8000
75.682
D
11655
I
by Trust
Common Stock
6025
D
Stock Options (Right to Buy)
51.55
2016-05-12
4
M
0
8000
51.55
D
2019-05-14
Common Stock
8000.0
0
I
by Trust
This transaction was executed in multiple trades at prices ranging from $75.67 to $75.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares reported as directly held on reporting person's previous Form 4 filing were subsequently transferred to a family trust in a transaction exempt from Section 16 under Rule 16a-13.
The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
The options vested in three equal annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.
/s/William J. O'Shaughnessy, Jr., Attorney in Fact for Jenne K. Britell
2016-05-16